Organic cation transporters

References

• Acquati F, Malgaretti N, Hauptschein R, Rao P, Gaidano G, Taramelli R. A 2-Mb YAC contig linking the plasminogen-apoprotein(a) gene family to the insulin-like growth factor 2 receptor (IGF2R) gene on the telomeric region of chromosome 6 (6q26-q27). Genomics 1994; 22: 664–666
   PubMedGoogle Scholar
• Alnouti Y, Petrick JS, Klaassen CD. Tissue distribution and ontogeny of organic cation transporters in mice. Drug Metabolism and Disposition 2006; 34: 477–482
   PubMed Web of Science ®Google Scholar
• Aoyama N, Takahashi N, Kitaichi K, Ishihara R, Saito S, Maeno N, Ji X, Takagi K, Sekine Y, Iyo M, et al. Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder. Alcoholism: Clinical and Experimental Research 2006; 30: 1644–1649
   PubMedGoogle Scholar
• Aperia AC. Intrarenal dopamine: A key signal in the interactive regulation of sodium metabolism. Annual Reviews in Physiology 2000; 62: 621–647
   PubMed Web of Science ®Google Scholar
• Arndt P, Volk C, Gorboulev V, Budiman T, Popp C, Ulzheimer-Teuber I, Akhoundova A, Koppatz S, Bamberg E, Nagel G, et al. Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1. American Journal of Physiology and Renal Physiology 2001; 281: F454–F468
   PubMed Web of Science ®Google Scholar
• Asaka J, Terada T, Okuda M, Katsura T, Inui K. Androgen receptor is responsible for rat organic cation transporter 2 gene regulation but not for rOCT1 and rOCT3. Pharmaceutical Research 2006; 23: 697–704
   PubMed Web of Science ®Google Scholar
• Barendt WM, Wright SH. The human organic cation transporter (hOCT2) recognizes the degree of substrate ionization. Journal of Biology and Chemistry 2002; 277: 22491–22496
   PubMed Web of Science ®Google Scholar
• Bednarczyk D, Ekins S, Wikel JH, Wright SH. Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1. Molecular Pharmacology 2003; 63: 489–498
   PubMed Web of Science ®Google Scholar
• Berkhin EB, Humphreys MH. Regulation of renal tubular secretion of organic compounds. Kidney International 2001; 59: 17–30
   PubMed Web of Science ®Google Scholar
• Biermann J, Lang D, Gorboulev V, Koepsell H, Sindic A, Schroter R, Zvirbliene A, Pavenstadt H, Schlatter E, Ciarimboli G. Characterization of regulatory mechanisms and states of human organic cation transporter 2. American Journal of Physiology and Cell Physiology 2006; 290: C1521–C1531
   PubMed Web of Science ®Google Scholar
• Bottalico B, Larsson I, Brodszki J, Hernandez-Andrade E, Casslen B, Marsal K, Hansson SR. Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies. Placenta 2004; 25: 518–529
   PubMed Web of Science ®Google Scholar
• Bourdet DL, Pritchard JB, Thakker DR. Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3). Journal of Pharmacology and Experimental Therapeutics 2005; 315: 1288–1297
   PubMed Web of Science ®Google Scholar
• Breidert T, Spitzenberger F, Gründemann D, Schomig E. Catecholamine transport by the organic cation transporter type 1 (OCT1). British Journal of Pharmacology 1998; 125: 218–224
   PubMed Web of Science ®Google Scholar
• Brown JB, Pedula K, Barzilay J, Herson MK, Latare P. Lactic acidosis rates in type 2 diabetes. Diabetes Care 1998; 21: 1659–1663
   PubMed Web of Science ®Google Scholar
• Budiman T, Bamberg E, Koepsell H, Nagel G. Mechanism of electrogenic cation transport by the cloned organic cation transporter 2 from rat. Journal of Biology and Chemistry 2000; 275: 29413–29420
   PubMed Web of Science ®Google Scholar
• Burckhardt G, Wolff NA. Structure of renal organic anion and cation transporters. American Journal of Physiology and Renal Physiology 2000; 278: F853–F866
   PubMed Web of Science ®Google Scholar
• Busch AE, Karbach U, Miska D, Gorboulev V, Akhoundova A, Volk C, Arndt P, Ulzheimer JC, Sonders MS, Baumann C, et al. Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Molecular Pharmacology 1998; 54: 342–352
   PubMed Web of Science ®Google Scholar
• Busch AE, Quester S, Ulzheimer JC, Gorboulev V, Akhoundova A, Waldegger S, Lang F, Koepsell H. Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1. FEBS Letters 1996a; 395: 153–156
   PubMed Web of Science ®Google Scholar
• Busch AE, Quester S, Ulzheimer JC, Waldegger S, Gorboulev V, Arndt P, Lang F, Koepsell H. Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1. Journal of Biology and Chemistry 1996b; 271: 32599–32604
   PubMed Web of Science ®Google Scholar
• Cetinkaya I, Ciarimboli G, Yalcinkaya G, Mehrens T, Velic A, Hirsch JR, Gorboulev V, Koepsell H, Schlatter E. Regulation of human organic cation transporter hOCT2 by PKA, PI3K, and calmodulin-dependent kinases. American Journal of Physiology and Renal Physiology 2003; 284: F293–F302
   PubMed Web of Science ®Google Scholar
• Chen R, Nelson JA. Role of organic cation transporters in the renal secretion of nucleosides. Biochemistry and Pharmacology 2000; 60: 215–219
   PubMed Web of Science ®Google Scholar
• Chen R, Jonker JW, Nelson JA. Renal organic cation and nucleoside transport. Biochemistry and Pharmacology 2002; 64: 185–190
   PubMed Web of Science ®Google Scholar
• Chen R, Pan BF, Sakurai M, Nelson JA. A nucleoside-sensitive organic cation transporter in opossum kidney cells. American Journal of Physiology 1999; 276: F323–F328
   Google Scholar
• Chen Y, Zhang S, Sorani M, Giacomini KM. Transport of paraquat by human organic cation transporters and multidrug and toxic compound extrusion family. The Journal of Pharmacology and Experimental Therapeutics 2007; 322: 695–700
   PubMed Web of Science ®Google Scholar
• Ciarimboli G, Schlatter E. Regulation of organic cation transport. Pflugers Archives 2005; 449: 423–441
   PubMed Web of Science ®Google Scholar
• Ciarimboli G, Koepsell H, Iordanova M, Gorboulev V, Dürner B, Lang D, Edemir B, Schröter R, Van Le T, Schlatter E. Individual PKC-phosphorylation sites in organic cation transporter 1 determine substrate selectivity and transport regulation. Journal of the American Society of Nephrology 2005a; 16: 1562–1570
   PubMed Web of Science ®Google Scholar
• Ciarimboli G, Ludwig T, Lang D, Pavenstadt H, Koepsell H, Piechota HJ, Haier J, Jaehde U, Zisowsky J, Schlatter E. Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2. American Journal of Pathology 2005b; 167: 1477–1484
   PubMed Web of Science ®Google Scholar
• Ciarimboli G, Struwe K, Arndt P, Gorboulev V, Koepsell H, Schlatter E, Hirsch JR. Regulation of the human organic cation transporter hOCT1. Journal of Cell Physiology 2004; 201: 420–428
   PubMed Web of Science ®Google Scholar
• Davidson MB, Peters AL. An overview of metformin in the treatment of type 2 diabetes mellitus. American Journal of Medicine 1997; 102: 99–110
   PubMed Web of Science ®Google Scholar
• Denk GU, Soroka CJ, Mennone A, Koepsell H, Beuers U, Boyer JL. Down-regulation of the organic cation transporter 1 of rat liver in obstructive cholestasis. Hepatology 2004; 39: 1382–1389
   PubMed Web of Science ®Google Scholar
• Dresser MJ, Xiao G, Leabman MK, Gray AT, Giacomini KM. Interactions of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2). Pharmaceutical Research 2002; 19: 1244–1247
   PubMed Web of Science ®Google Scholar
• Dudley AJ, Bleasby K, Brown CD. The organic cation transporter OCT2 mediates the uptake of beta-adrenoceptor antagonists across the apical membrane of renal LLC-PK(1) cell monolayers. British Journal of Pharmacology 2000; 131: 71–79
   PubMed Web of Science ®Google Scholar
• Eraly SA, Hamilton BA, Nigam SK. Organic anion and cation transporters occur in pairs of similar and similarly expressed genes. Biochemical and Biophysical Research Communications 2003; 300: 333–342
   PubMed Web of Science ®Google Scholar
• Eraly SA, Monte JC, Nigam SK. Novel slc22 transporter homologs in fly, worm, and human clarify the phylogeny of organic anion and cation transporters. Physiology Genomics 2004; 18: 12–24
   PubMed Web of Science ®Google Scholar
• Fukushima-Uesaka H, Maekawa K, Ozawa S, Komamura K, Ueno K, Shibakawa M, Kamakura S, Kitakaze M, Tomoike H, Saito Y, et al. Fourteen novel single nucleotide polymorphisms in the SLC22A2 gene encoding human organic cation transporter (OCT2). Drug Metabolism and Pharmacokinetics 2004; 19: 239–244
   PubMedGoogle Scholar
• Gasser PJ, Lowry CA, Orchinik M. Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: Potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission. Journal of Neuroscience 2006; 26: 8758–8766
   PubMed Web of Science ®Google Scholar
• Gorboulev V, Shatskaya N, Volk C, Koepsell H. Subtype-specific affinity for corticosterone of rat organic cation transporters rOCT1 and rOCT2 depends on three amino acids within the substrate binding region. Molecular Pharmacology 2005; 67: 1612–1619
   PubMed Web of Science ®Google Scholar
• Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S, Baumann C, Lang F, Busch AE, Koepsell H. Cloning and characterization of two human polyspecific organic cation transporters. DNA Cell Biology 1997; 16: 871–881
   PubMed Web of Science ®Google Scholar
• Gorboulev V, Volk C, Arndt P, Akhoundova A, Koepsell H. Selectivity of the polyspecific cation transporter rOCT1 is changed by mutation of aspartate 475 to glutamate. Molecular Pharmacology 1999; 56: 1254–1261
   PubMed Web of Science ®Google Scholar
• Gorbunov D, Gorboulev V, Shatskaya N, Mueller T, Bamberg E, Friedrich T, Koepsell H. High-affinity cation binding to transporter OCT1 induces movement of helix 11 and blocks transport after mutations in a modelled interaction domain between two helices. Molecular Pharmacology 2008; 73: 50–61
   PubMed Web of Science ®Google Scholar
• Green RM, Lo K, Sterritt C, Beier DR. Cloning and functional expression of a mouse liver organic cation transporter. Hepatology 1999; 29: 1556–1562
   PubMed Web of Science ®Google Scholar
• Grover B, Auberger C, Sarangarajan R, Cacini W. Functional impairment of renal organic cation transport in experimental diabetes. Pharmacology and Toxicology 2002; 90: 181–186
   PubMedGoogle Scholar
• Grover B, Buckley D, Buckley AR, Cacini W. Reduced expression of organic cation transporters rOCT1 and rOCT2 in experimental diabetes. Journal of Pharmacology and Experimental Therapeutics 2004; 308: 949–956
   PubMed Web of Science ®Google Scholar
• Groves CE, Suhre WB, Cherrington NJ, Wright SH. Sex differences in the mRNA, protein, and functional expression of organic anion transporter (Oat) 1, Oat3, and organic cation transporter (Oct) 2 in rabbit renal proximal tubules. Journal of Pharmacology and Experimental Therapeutics 2006; 316: 743–752
   PubMed Web of Science ®Google Scholar
• Gründemann D, Schomig E. Gene structures of the human non-neuronal monoamine transporter EMT and OCT2. Human Genetics 2000; 106: 627–635
   PubMedGoogle Scholar
• Gründemann D, Babin-Ebell J, Martel F, Ording N, Schmidt A, Schomig E. Primary structure and functional expression of the apical organic cation transporter from kidney epithelial LLC-PK1 cells. Journal of Biology and Chemistry 1997; 272: 10408–10413
   PubMed Web of Science ®Google Scholar
• Gründemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H. Drug excretion mediated by a new prototype of polyspecific transporter. Nature 1994; 372: 549–552
   PubMed Web of Science ®Google Scholar
• Gründemann D, Hahne C, Berkels R, Schömig E. Agmatine is efficiently transported by non-neuronal monoamine transporters extraneuronal monoamine transporter (EMT) and organic cation transporter 2 (OCT2). Journal of Pharmacology and Experimental Therapeutics 2003; 304: 810–817
   PubMed Web of Science ®Google Scholar
• Gründemann D, Koschker AC, Haag C, Honold C, Zimmermann T, Schömig E. Activation of the extraneuronal monoamine transporter (EMT) from rat expressed in 293 cells. British Journal of Pharmacology 2002; 137: 910–918
   PubMedGoogle Scholar
• Gründemann D, Koster S, Kiefer N, Breidert T, Engelhardt M, Spitzenberger F, Obermuller N, Schomig E. Transport of monoamine transmitters by the organic cation transporter type 2, OCT2. Journal of Biology and Chemistry 1998a; 273: 30915–30920
   PubMed Web of Science ®Google Scholar
• Gründemann D, Liebich G, Kiefer N, Koster S, Schomig E. Selective substrates for non-neuronal monoamine transporters. Molecular Pharmacology 1999; 56: 1–10
   PubMed Web of Science ®Google Scholar
• Gründemann D, Schechinger B, Rappold GA, Schömig E. Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter. Nature Neuroscience 1998b; 1: 349–351
   PubMed Web of Science ®Google Scholar
• Habu Y, Yano I, Takeuchi A, Saito H, Okuda M, Fukatsu A, Inui K. Decreased activity of basolateral organic ion transports in hyperuricemic rat kidney: Roles of organic ion transporters, rOAT1, rOAT3 and rOCT2. Biochemistry and Pharmacology 2003; 66: 1107–1114
   PubMed Web of Science ®Google Scholar
• Hasannejad H, Takeda M, Narikawa S, Huang XL, Enomoto A, Taki K, Niwa T, Jung SH, Onozato ML, Tojo A, et al. Human organic cation transporter 3 mediates the transport of antiarrhythmic drugs. European Journal of Pharmacology 2004; 499: 45–51
   PubMed Web of Science ®Google Scholar
• Hayer-Zillgen M, Bruss M, Bonisch H. Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3. British Journal of Pharmacology 2002; 136: 829–836
   PubMed Web of Science ®Google Scholar
• Hediger MA, Romero MF, Peng JB, Rolfs A, Takanaga H, Bruford EA. The ABCs of solute carriers: Physiological, pathological and therapeutic implications of human membrane transport proteins. Introduction. Pflugers Archives 2004; 447: 465–468
   PubMed Web of Science ®Google Scholar
• Hohage H, Morth DM, Querl IU, Greven J. Regulation by protein kinase C of the contraluminal transport system for organic cations in rabbit kidney S2 proximal tubules. Journal of Pharmacology and Experimental Therapeutics 1994; 268: 897–901
   PubMed Web of Science ®Google Scholar
• Itoda M, Saito Y, Maekawa K, Hichiya H, Komamura K, Kamakura S, Kitakaze M, Tomoike H, Ueno K, Ozawa S. Seven novel single nucleotide polymorphisms in the human SLC22A1 gene encoding organic cation transporter 1 (OCT1). Drug Metabolism and Pharmacokinetics 2004; 19: 308–312
   PubMedGoogle Scholar
• Izzedine H, Launay-Vacher V, Deray G. Renal tubular transporters and antiviral drugs: An update. AIDS 2005; 19: 455–462
   PubMed Web of Science ®Google Scholar
• Ji L, Masuda S, Saito H, Inui K. Down-regulation of rat organic cation transporter rOCT2 by 5/6 nephrectomy. Kidney International 2002; 62: 514–524
   PubMed Web of Science ®Google Scholar
• Jonker JW, Wagenaar E, Mol CA, Buitelaar M, Koepsell H, Smit JW, Schinkel AH. Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene. Molecular Cell Biology 2001; 21: 5471–5477
   PubMed Web of Science ®Google Scholar
• Jonker JW, Wagenaar E, Van Eijl S, Schinkel AH. Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations. Molecular Cell Biology 2003; 23: 7902–7908
   PubMed Web of Science ®Google Scholar
• Kaewmokul S, Chatsudthipong V, Evans KK, Dantzler WH, Wright SH. Functional mapping of rbOCT1 and rbOCT2 activity in the S2 segment of rabbit proximal tubule. American Journal of Physiology and Renal Physiology 2003; 285: F1149–F1159
   Google Scholar
• Kakehi M, Koyabu N, Nakamura T, Uchiumi T, Kuwano M, Ohtani H, Sawada Y. Functional characterization of mouse cation transporter mOCT2 compared with mOCT1. Biochemical and Biophysical Research Communications 2002; 296: 644–650
   PubMedGoogle Scholar
• Kakuda TN, Struble KA, Piscitelli SC. Protease inhibitors for the treatment of human immunodeficiency virus infection. American Journal of Health-Systems Pharmacy 1998; 55: 233–254
   PubMed Web of Science ®Google Scholar
• Kalow W, Endrenyi L, Tang B. Repeat administration of drugs as a means to assess the genetic component in pharmacological variability. Pharmacology 1999; 58: 281–284
   PubMed Web of Science ®Google Scholar
• Karbach U, Kricke J, Meyer-Wentrup F, Gorboulev V, Volk C, Loffing-Cueni D, Kaissling B, Bachmann S, Koepsell H. Localization of organic cation transporters OCT1 and OCT2 in rat kidney. American Journal of Physiology and Renal Physiology 2000; 279: F679–F687
   PubMed Web of Science ®Google Scholar
• Kekuda R, Prasad PD, Wu X, Wang H, Fei YJ, Leibach FH, Ganapathy V. Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. Journal of Biology and Chemistry 1998; 273: 15971–15979
   PubMed Web of Science ®Google Scholar
• Kerb R. Implications of genetic polymorphisms in drug transporters for pharmacotherapy. Cancer Letters 2006; 234: 4–33
   PubMed Web of Science ®Google Scholar
• Kerb R, Brinkmann U, Chatskaia N, Gorbunov D, Gorboulev V, Mornhinweg E, Keil A, Eichelbaum M, Koepsell H. Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences. Pharmacogenetics 2002; 12: 591–595
   PubMedGoogle Scholar
• Khamdang S, Takeda M, Noshiro R, Narikawa S, Enomoto A, Anzai N, Piyachaturawat P, Endou H. Interactions of human organic anion transporters and human organic cation transporters with nonsteroidal anti-inflammatory drugs. Journal of Pharmacology and Experimental Therapeutics 2002; 303: 534–539
   PubMed Web of Science ®Google Scholar
• Kimura H, Takeda M, Narikawa S, Enomoto A, Ichida K, Endou H. Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins. Journal of Pharmacology and Experimental Therapeutics 2002; 301: 293–298
   PubMed Web of Science ®Google Scholar
• Kimura N, Masuda S, Tanihara Y, Ueo H, Okuda M, Katsura T, Inui K. Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1. Drug Metabolism and Pharmacokinetics 2005a; 20: 379–386
   PubMedGoogle Scholar
• Kimura N, Okuda M, Inui K. Metformin transport by renal basolateral organic cation transporter hOCT2. Pharmaceutical Research 2005b; 22: 255–259
   PubMed Web of Science ®Google Scholar
• Kitaichi K, Morishita Y, Doi Y, Ueyama J, Matsushima M, Zhao YL, Takagi K, Hasegawa T. Increased plasma concentration and brain penetration of methamphetamine in behaviorally sensitized rats. European Journal of Pharmacology 2003; 464: 39–48
   PubMedGoogle Scholar
• Koehler MR, Gorboulev V, Koepsell H, Steinlein C, Schmid M. Roct1, a rat polyspecific transporte gene for the excretion of cationic drugs, maps to chromosome 1q11–12. Mammalian Genome 1996; 7: 247–248
   PubMedGoogle Scholar
• Koehler MR, Wissinger B, Gorboulev V, Koepsell H, Schmid M. The two human organic cation transporter genes SLC22A1 and SLC22A2 are located on chromosome 6q26. Cytogenetics and Cell Genetics 1997; 79: 198–200
   PubMedGoogle Scholar
• Koepsell H. Organic cation transporters in intestine, kidney, liver, and brain. Annual Reviews in Physiology 1998; 60: 243–266
   PubMed Web of Science ®Google Scholar
• Koepsell H. Polyspecific organic cation transporters: Their functions and interactions with drugs. Trends in Pharmacology Science 2004; 25: 375–381
   PubMed Web of Science ®Google Scholar
• Koepsell H, Endou H. The SLC22 drug transporter family. Pflugers Archives 2004; 447: 666–676
   PubMed Web of Science ®Google Scholar
• Koepsell H, Lips K, Volk C. Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications. Pharmaceutical Research 2007; 24: 1227–1251
   PubMed Web of Science ®Google Scholar
• Koepsell H, Schmitt BM, Gorboulev V. Organic cation transporters. Reviews in Physiology. Biochemistry and Pharmacology 2003; 150: 36–90
   Google Scholar
• Kummer W, Wiegand S, Akinci S, Wessler I, Schinkel AH, Wess J, Koepsell H, Haberberger RV, Lips KS. Role of acetylcholine and polyspecific cation transporters in serotonin-induced bronchoconstriction in the mouse. 2006, Respiratory Research 7:65
   Google Scholar
• Kuttesch Jr JF, Robins MJ, Nelson JA. Renal transport of 2′-deoxytubercidin in mice. Biochemistry and Pharmacology 1982; 31: 3387–3394
   PubMedGoogle Scholar
• Lazar A, Grundemann D, Berkels R, Taubert D, Zimmermann T, Schomig E. Genetic variability of the extraneuronal monoamine transporter EMT (SLC22A3). Journal of Human Genetics 2003; 48: 226–230
   PubMedGoogle Scholar
• Lazar A, Zimmermann T, Koch W, Grundemann D, Schomig A, Kastrati A, Schomig E. Lower prevalence of the OCT2 Ser270 allele in patients with essential hypertension. Clinical Experiments in Hypertension 2006; 28: 645–653
   PubMed Web of Science ®Google Scholar
• Leabman MK, Huang CC, DeYoung J, Carlson EJ, Taylor TR, De La CM, Johns SJ, Stryke D, Kawamoto M, Urban TJ, et al. Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proceedings of the National Academy of Sciences, USA, 2003. 100: 5896–5901
   Google Scholar
• Leabman MK, Huang CC, Kawamoto M, Johns SJ, Stryke D, Ferrin TE, DeYoung J, Taylor T, Clark AG, Herskowitz I, et al. Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function. Pharmacogenetics 2002; 12: 395–405
   PubMedGoogle Scholar
• Lee CG, Gottesman MM, Cardarelli CO, Ramachandra M, Jeang KT, Ambudkar SV, Pastan I, Dey S. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter. Biochemistry 1998; 37: 3594–3601
   PubMed Web of Science ®Google Scholar
• Li Q, Sai Y, Kato Y, Muraoka H, Tamai I, Tsuji A. Transporter-mediated renal handling of nafamostat mesilate. Journal of Pharmacology Science 2004; 93: 262–272
   PubMed Web of Science ®Google Scholar
• Lips KS, Volk C, Schmitt BM, Pfeil U, Arndt P, Miska D, Ermert L, Kummer W, Koepsell H. Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium. American Journal of Respiration and Cell Molecular Biology 2005; 33: 79–88
   PubMed Web of Science ®Google Scholar
• Martel F, Keating E, Calhau C, Gründemann D, Schömig E, Azevedo I. Regulation of human extraneuronal monoamine transporter (hEMT) expressed in HEK293 cells by intracellular second messenger systems. Naunyn-Schmiedeberg's Archives in Pharmacology 2001; 364: 487–495
   PubMed Web of Science ®Google Scholar
• Martel F, Ribeiro L, Calhau C, Azevedo I. Inhibition by levamisole of the organic cation transporter rOCT1 in cultured rat hepatocytes. Pharmacology Research 1999; 40: 275–279
   Google Scholar
• Mehrens T, Lelleck S, Cetinkaya I, Knollmann M, Hohage H, Gorboulev V, Boknik P, Koepsell H, Schlatter E. The affinity of the organic cation transporter rOCT1 is increased by protein kinase C-dependent phosphorylation. Journal of the American Society of Nephrology 2000; 11: 1216–1224
   PubMed Web of Science ®Google Scholar
• Meyer-Wentrup F, Karbach U, Gorboulev V, Arndt P, Koepsell H. Membrane localization of the electrogenic cation transporter rOCT1 in rat liver. Biochemical and Biophysical Research Communications 1998; 248: 673–678
   PubMed Web of Science ®Google Scholar
• Miakotina OL, Agassandian M, Shi L, Look DC, Mallampalli RK. Adenovirus stimulates choline efflux by increasing expression of organic cation transporter-2. American Journal of Physiology, Lung and Cell Molecular Physiology 2005; 288: L93–L102
   PubMed Web of Science ®Google Scholar
• Moaddel R, Ravichandran S, Bighi F, Yamaguchi R, Wainer IW. Pharmacophore modelling of stereoselective binding to the human organic cation transporter (hOCT1). British Journal of Pharmacology 2007; 151: 1305–1314
   PubMed Web of Science ®Google Scholar
• Mooslehner KA, Allen ND. Cloning of the mouse organic cation transporter 2 gene, Slc22a2, from an enhancer-trap transgene integration locus. Mammalian Genome 1999; 10: 218–224
   PubMed Web of Science ®Google Scholar
• Motohashi H, Sakurai Y, Saito H, Masuda S, Urakami Y, Goto M, Fukatsu A, Ogawa O, Inui KK. Gene expression levels and immunolocalization of organic ion transporters in the human kidney. Journal of the American Society of Nephrology 2002; 13: 866–874
   PubMed Web of Science ®Google Scholar
• Muller J, Lips KS, Metzner L, Neubert RH, Koepsell H, Brandsch M. Drug specificity and intestinal membrane localization of human organic cation transporters (OCT). Biochemistry and Pharmacology 2005; 70: 1851–1860
   PubMed Web of Science ®Google Scholar
• Nagel G, Volk C, Friedrich T, Ulzheimer JC, Bamberg E, Koepsell H. A reevaluation of substrate specificity of the rat cation transporter rOCT1. Journal of Biology and Chemistry 1997; 272: 31953–31956
   PubMed Web of Science ®Google Scholar
• Nie W, Sweetser S, Rinella M, Green RM. Transcriptional regulation of murine Slc22a1 (Oct1) by peroxisome proliferator agonist receptor-alpha and -gamma. American Journal of Physiology, Gastrointestinal and Liver Physiology 2005; 288: G207–G212
   PubMed Web of Science ®Google Scholar
• Ogasawara M, Yamauchi K, Satoh Y, Yamaji R, Inui K, Jonker JW, Schinkel AH, Maeyama K. Recent advances in molecular pharmacology of the histamine systems: Organic cation transporters as a histamine transporter and histamine metabolism. Journal of Pharmacology Science 2006; 101: 24–30
   Google Scholar
• Okuda M, Saito H, Urakami Y, Takano M, Inui K. cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochemical and Biophysical Research Communications 1996; 224: 500–507
   PubMed Web of Science ®Google Scholar
• Pavlova A, Sakurai H, Leclercq B, Beier DR, Yu AS, Nigam SK. Developmentally regulated expression of organic ion transporters NKT (OAT1), OCT1, NLT (OAT2), and Roct. American Journal of Physiology and Renal Physiology 2000; 278: F635–F643
   PubMed Web of Science ®Google Scholar
• Pelis RM, Suhre WM, Wright SH. Functional influence of N-glycosylation in OCT2-mediated tetraethylammonium transport. American Journal of Physiology and Renal Physiology 2006a; 290: F1118–F1126
   PubMed Web of Science ®Google Scholar
• Pelis RM, Zhang X, Dangprapai Y, Wright SH. Cysteine accessibility in the hydrophilic cleft of the human organic cation transporter 2. Journal of Biology and Chemistry 2006b; 281: 35272–35280
   PubMedGoogle Scholar
• Pietig G, Mehrens T, Hirsch JR, Cetinkaya I, Piechota H, Schlatter E. Properties and regulation of organic cation transport in freshly isolated human proximal tubules. Journal of Biology and Chemistry 2001; 276: 33741–33746
   PubMedGoogle Scholar
• Popp C, Gorboulev V, Muller TD, Gorbunov D, Shatskaya N, Koepsell H. Amino acids critical for substrate affinity of rat organic cation transporter 1 line the substrate binding region in a model derived from the tertiary structure of lactose permease. Molecular Pharmacology 2005; 67: 1600–1611
   PubMed Web of Science ®Google Scholar
• Ren Q, Paulsen IT. Comparative analyses of fundamental differences in membrane transport capabilities in prokaryotes and eukaryotes. PLoS Computational Biology 2005; 1: e27
   PubMedGoogle Scholar
• Romero MF, Kanai Y, Gunshin H, Hediger MA. Expression cloning using Xenopus laevis oocytes. Methods in Enzymology 1998; 296: 17–52
   PubMedGoogle Scholar
• Saborowski M, Kullak-Ublick GA, Eloranta JJ. The human organic cation transporter-1 gene is transactivated by hepatocyte nuclear factor-4alpha. Journal of Pharmacology and Experimental Therapeutics 2006; 317: 778–785
   PubMed Web of Science ®Google Scholar
• Saier MH. A functional-phylogenetic classification system for transmembrane solute transporters. Microbiology and Molecular Biology Reviews 2000a; 64: 354–411
   PubMed Web of Science ®Google Scholar
• Saier MH. Vectorial metabolism and the evolution of transport systems. Journal of Bacteriology 2000b; 182: 5029–5035
   PubMedGoogle Scholar
• Sata R, Ohtani H, Tsujimoto M, Murakami H, Koyabu N, Nakamura T, Uchiumi T, Kuwano M, Nagata H, Tsukimori K, et al. Functional analysis of organic cation transporter 3 expressed in human placenta. Journal of Pharmacology and Experimental Therapeutics 2005; 315: 888–895
   PubMed Web of Science ®Google Scholar
• Schlatter E, Mönnich V, Cetinkaya I, Mehrens T, Ciarimboli G, Hirsch JR, Popp C, Koepsell H. The organic cation transporters rOCT1 and hOCT2 are inhibited by cGMP. Journal of Membrane Biology 2002; 189: 237–244
   PubMed Web of Science ®Google Scholar
• Schweifer N, Barlow DP. The Lx1 gene maps to mouse chromosome 17 and codes for a protein that is homologous to glucose and polyspecific transmembrane transporters. Mammalian Genome 1996; 7: 735–740
   PubMed Web of Science ®Google Scholar
• Shang T, Uihlein AV, Van Asten J, Kalyanaraman B, Hillard CJ. 1-Methyl-4-phenylpyridinium accumulates in cerebellar granule neurons via organic cation transporter 3. Journal of Neurochemistry 2003; 85: 358–367
   PubMed Web of Science ®Google Scholar
• Shikata E, Yamamoto R, Takane H, Shigemasa C, Ikeda T, Otsubo K, Ieiri I. Human organic cation transporter (OCT1 and OCT2) gene polymorphisms and therapeutic effects of metformin. Journal of Human Genetics 2006; 52: 117–122
   PubMedGoogle Scholar
• Shu Y, Leabman MK, Feng B, Mangravite LM, Huang CC, Stryke D, Kawamoto M, Johns SJ, DeYoung J, Carlson E, et al. Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proceedings of the National Academy of Sciences, USA, 2003. 100: 5902–5907
   Google Scholar
• Shu Y, Sheardown SA, Brown C, Owen RP, Zhang S, Castro RA, Ianculescu AG, Yue L, Lo JC, Burchard EG, et al. Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. Journal of Clinical Investigation 2007; 117: 1422–1431
   PubMed Web of Science ®Google Scholar
• Soodvilai S, Chatsudthipong A, Chatsudthipong V. Role of MAPK and PKA in regulation of rbOCT2-mediated renal organic cation transport. American Journal of Physiology and Renal Physiology 2007; 293: F21–F27
   Google Scholar
• Suhre WM, Ekins S, Chang C, Swaan PW, Wright SH. Molecular determinants of substrate/inhibitor binding to the human and rabbit renal organic cation transporters hOCT2 and rbOCT2. Molecular Pharmacology 2005; 67: 1067–1077
   PubMed Web of Science ®Google Scholar
• Sweet DH, Pritchard JB. rOCT2 is a basolateral potential-driven carrier, not an organic cation/proton exchanger. American Journal of Physiology 1999; 277: F890–F898
   PubMed Web of Science ®Google Scholar
• Sweet DH, Eraly SA, Vaughn DA, Bush KT, Nigam SK. Organic anion and cation transporter expression and function during embryonic kidney development and in organ culture models. Kidney International 2006; 69: 837–845
   PubMed Web of Science ®Google Scholar
• Sweet DH, Miller DS, Pritchard JB. Ventricular choline transport: A role for organic cation transporter 2 expressed in choroid plexus. Journal of Biology and Chemistry 2001; 276: 41611–41619
   PubMed Web of Science ®Google Scholar
• Takeda M, Khamdang S, Narikawa S, Kimura H, Kobayashi Y, Yamamoto T, Cha SH, Sekine T, Endou H. Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. Journal of Pharmacology and Experimental Therapeutics 2002; 300: 918–924
   PubMed Web of Science ®Google Scholar
• Takeuchi A, Motohashi H, Okuda M, Inui K. Decreased function of genetic variants, Pro283Leu and Arg287Gly, in human organic cation transporter hOCT1. Drug Metabolism and Pharmacokinetics 2003; 18: 409–412
   PubMedGoogle Scholar
• Taubert D, Grimberg G, Stenzel W, Schomig E. Identification of the endogenous key substrates of the human organic cation transporter OCT2 and their implication in function of dopaminergic neurons. PLoS ONE 2007; 2: e385
   PubMed Web of Science ®Google Scholar
• Terashita S, Dresser MJ, Zhang L, Gray AT, Yost SC, Giacomini KM. Molecular cloning and functional expression of a rabbit renal organic cation transporter. Biochimica et Biophysica Acta 1998; 1369: 1–6
   PubMed Web of Science ®Google Scholar
• Thomas MC, Tikellis C, Burns WC, Thallas V, Forbes JM, Cao Z, Osicka TM, Russo LM, Jerums G, Ghabrial H, et al. Reduced tubular cation transport in diabetes: Prevented by ACE inhibition. Kidney International 2003; 63: 2152–2161
   PubMed Web of Science ®Google Scholar
• Thomas MC, Tikellis C, Kantharidis P, Burns WC, Cooper ME, Forbes JM. The role of advanced glycation in reduced organic cation transport associated with experimental diabetes. Journal of Pharmacology and Experimental Therapeutics 2004; 311: 456–466
   PubMed Web of Science ®Google Scholar
• Tsuruoka S, Ioka T, Wakaumi M, Sakamoto K, Ookami H, Fujimura A. Severe arrhythmia as a result of the interaction of cetirizine and pilsicainide in a patient with renal insufficiency: First case presentation showing competition for excretion via renal multidrug resistance protein 1 and organic cation transporter 2. Clinical Pharmacology and Therapy 2006; 79: 389–396
   PubMed Web of Science ®Google Scholar
• Urakami Y, Akazawa M, Saito H, Okuda M, Inui K. cDNA cloning, functional characterization, and tissue distribution of an alternatively spliced variant of organic cation transporter hOCT2 predominantly expressed in the human kidney. Journal of the American Society of Nephrology 2002; 13: 1703–1710
   PubMed Web of Science ®Google Scholar
• Urakami Y, Nakamura N, Takahashi K, Okuda M, Saito H, Hashimoto Y, Inui K. Gender differences in expression of organic cation transporter OCT2 in rat kidney. FEBS Letters 1999; 461: 339–342
   PubMed Web of Science ®Google Scholar
• Urakami Y, Okuda M, Masuda S, Saito H, Inui KI. Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs. Journal of Pharmacology and Experimental Therapeutics 1998; 287: 800–805
   PubMed Web of Science ®Google Scholar
• Urakami Y, Okuda M, Saito H, Inui K. Hormonal regulation of organic cation transporter OCT2 expression in rat kidney. FEBS Letters 2000; 473: 173–176
   PubMed Web of Science ®Google Scholar
• Van Montfoort JE, Hagenbuch B, Groothuis GM, Koepsell H, Meier PJ, Meijer DK. Drug uptake systems in liver and kidney. Current Drug Metabolism 2003; 4: 185–211
   PubMed Web of Science ®Google Scholar
• Verhaagh S, Schweifer N, Barlow DP, Zwart R. Cloning of the mouse and human solute carrier 22a3 (Slc22a3/SLC22A3) identifies a conserved cluster of three organic cation transporters on mouse chromosome 17 and human 6q26–q27. Genomics 1999; 55: 209–218
   PubMed Web of Science ®Google Scholar
• Vialou V, Amphoux A, Zwart R, Giros B, Gautron S. Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation. Journal of Neuroscience 2004; 24: 2846–2851
   PubMed Web of Science ®Google Scholar
• Volk C, Gorboulev V, Budiman T, Nagel G, Koepsell H. Different affinities of inhibitors to the outwardly and inwardly directed substrate binding site of organic cation transporter 2. Molecular Pharmacology 2003; 64: 1037–1047
   PubMed Web of Science ®Google Scholar
• Wang DS, Jonker JW, Kato Y, Kusuhara H, Schinkel AH, Sugiyama Y. Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin. Journal of Pharmacology and Experimental Therapeutics 2002; 302: 510–515
   PubMed Web of Science ®Google Scholar
• Wang DS, Kusuhara H, Kato Y, Jonker JW, Schinkel AH, Sugiyama Y. Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin. Molecular Pharmacology 2003; 63: 844–848
   PubMed Web of Science ®Google Scholar
• Wang L, Giannoudis A, Lane S, Williamson P, Pirmohamed M, Clark RE. Expression of the uptake drug transporter hOCT1 is an important clinical determinant of the response to imatinib in chronic myeloid leukemia. Clinical Pharmacology and Therapy 2008; 83: 258–264
   PubMed Web of Science ®Google Scholar
• Wessler I, Kilbinger H, Bittinger F, Unger R, Kirkpatrick CJ. The non-neuronal cholinergic system in humans: Expression, function and pathophysiology. Life Science 2003; 72: 2055–2061
   PubMed Web of Science ®Google Scholar
• Wessler I, Roth E, Deutsch C, Brockerhoff P, Bittinger F, Kirkpatrick CJ, Kilbinger H. Release of non-neuronal acetylcholine from the isolated human placenta is mediated by organic cation transporters. British Journal of Pharmacology 2001; 134: 951–956
   PubMed Web of Science ®Google Scholar
• Wright SH, Dantzler WH. Molecular and cellular physiology of renal organic cation and anion transport. Physiology Reviews 2004; 84: 987–1049
   PubMed Web of Science ®Google Scholar
• Wright SH, Evans KK, Zhang X, Cherrington NJ, Sitar DS, Dantzler WH. Functional map of TEA transport activity in isolated rabbit renal proximal tubules. American Journal of Physiology and Renal Physiology 2004; 287: F442–F451
   Google Scholar
• Wu X, Kekuda R, Huang W, Fei YJ, Leibach FH, Chen J, Conway SJ, Ganapathy V. Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. Journal of Biology and Chemistry 1998; 273: 32776–32786
   PubMed Web of Science ®Google Scholar
• Yonezawa A, Masuda S, Nishihara K, Yano I, Katsura T, Inui K. Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat. Biochemistry and Pharmacology 2005; 70: 1823–1831
   PubMed Web of Science ®Google Scholar
• Yonezawa A, Masuda S, Yokoo S, Katsura T, Inui K. Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1–3 and multidrug and toxin extrusion family). Journal of Pharmacology and Experimental Therapeutics 2006; 319: 879–886
   PubMed Web of Science ®Google Scholar
• Zhang L, Brett CM, Giacomini K. Role of organic cation transporters in drug absorption and elimination. Annual Reviews in Pharmacology and Toxicology 1998a; 38: 431–460
   PubMed Web of Science ®Google Scholar
• Zhang L, Dresser MJ, Chun JK, Babbitt PC, Giacomini KM. Cloning and functional characterization of a rat renal organic cation transporter isoform (rOCT1A). Journal of Biology and Chemistry 1997a; 272: 16548–16554
   PubMed Web of Science ®Google Scholar
• Zhang L, Dresser MJ, Gray AT, Yost SC, Terashita S, Giacomini KM. Cloning and functional expression of a human liver organic cation transporter. Molecular Pharmacology 1997b; 51: 913–921
   PubMed Web of Science ®Google Scholar
• Zhang L, Gorset W, Dresser MJ, Giacomini KM. The interaction of n-tetraalkylammonium compounds with a human organic cation transporter, hOCT1. Journal of Pharmacology and Experimental Therapeutics 1999; 288: 1192–1198
   PubMed Web of Science ®Google Scholar
• Zhang L, Gorset W, Washington CB, Blaschke TF, Kroetz DL, Giacomini KM. Interactions of HIV protease inhibitors with a human organic cation transporter in a mammalian expression system. Drug Metabolism and Disposition 2000; 28: 329–334
   PubMed Web of Science ®Google Scholar
• Zhang L, Schaner ME, Giacomini KM. Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa). Journal of Pharmacology and Experimental Therapeutics 1998b; 286: 354–361
   PubMed Web of Science ®Google Scholar
• Zhang S, Lovejoy KS, Shima JE, Lagpacan LL, Shu Y, Lapuk A, Chen Y, Komori T, Gray JW, Chen X, et al. Organic cation transporters are determinants of oxaliplatin cytotoxicity. Cancer Research 2006; 66: 8847–8857
   PubMed Web of Science ®Google Scholar
• Zhang X, Evans KK, Wright SH. Molecular cloning of rabbit organic cation transporter rbOCT2 and functional comparisons with rbOCT1. American Journal of Physiology and Renal Physiology 2002; 283: F124–F133
   PubMed Web of Science ®Google Scholar
• Zhang X, Groves CE, Bahn A, Barendt WM, Prado MD, Rodiger M, Chatsudthipong V, Burckhardt G, Wright SH. Relative contribution of OAT and OCT transporters to organic electrolyte transport in rabbit proximal tubule. American Journal of Physiology Renal Physiology 2004; 287: F999–F1010
   PubMed Web of Science ®Google Scholar
• Zwart R, Verhaagh S, Buitelaar M, Popp-Snijders C, Barlow DP. Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-deficient mice. Molecular Cell Biology 2001; 21: 4188–4196
   PubMed Web of Science ®Google Scholar